Frequently Asked Questions
Healthcare professionals heavily used anti-inflammatory medications during the height of the pandemic crisis to relieve complications suffered by severely ill and immunocompromised patients.
North America accounted for the most heightened share in the global Rare Inflammatory Disease Treatment market.
The market demand for rare inflammatory disease treatments has been further boosted by rising R&D expenditures for various drug developments and demand for various drug administration methods.
The biologics segment had a major share in the global market in 2022.
The hospital pharmacy segment had a major share in the global market.